TGFB1 and neoplasm: Finally, myeloid-derived suppressor cells and tumor-associated macrophages contribute to immunosuppressive tumor microenvironments by releasing IL-10, TGF-β, arginase, and VEGF, affecting both species and providing a rationale for cross-species evaluation of immune therapies [13].